The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT05332457 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-03-24
Summary
This is a prospective study to evaluate changes in exercise capacity and chronotropic response to exercise before and after beta-blocker dosage reduction in patients with atrial fibrillation (AF).
Conditions
Interventions
- DRUG
-
Reduced dosage of beta-blocker
Phase I: 1. CPET performed at trough BB concentration: participants will undergo CPET at least 30 hours after last beta-blocker usage. 2. CPET performed at peak BB concentration : participants will undergo CPET at 3 hours after last beta-blocker usage. Phase II: BB dosage will be reduced.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Hung-Jui Chuang, MD · Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Impact of Beta Blockers on TAVI (BETA-TAVI)
NCT05721170 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Nebulized Bronchodilators on Heart Rate
NCT01151579 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects
NCT00588965 ·Status: COMPLETED ·Phase: NA
-
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT00288548 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
NCT06864234 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Continuous Heart Rate Monitoring in Healthy Participants
NCT04682184 ·Status: COMPLETED ·Phase: NA
-
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
NCT04564365 ·Status: UNKNOWN
-
Analysis of Atropine and Propranolol Induced Changes
NCT00251602 ·Status: COMPLETED ·Phase: PHASE1
-
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
NCT00925119 ·Status: TERMINATED ·Phase: PHASE4
-
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
NCT07268170 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
A Study of Lasmiditan and Propranolol in Healthy Participants
NCT03270644 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable,Symptomatic Chronic Angina
NCT02623569 ·Status: UNKNOWN ·Phase: PHASE2
-
Race, Natriuretic Peptides and Physiological Perturbations
NCT03070184 ·Status: COMPLETED ·Phase: PHASE2
-
The Nitrite and Coronary Flow Study
NCT04354051 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
NCT01022463 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
NCT01397994 ·Status: UNKNOWN ·Phase: PHASE4
-
The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
NCT01029223 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Genetic Polymorphisms on Response to Beta Blocker Therapy in Egyptian Patients
NCT04900545 ·Status: COMPLETED
-
De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease
NCT05081999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055 ·Status: RECRUITING ·Phase: PHASE4
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
NCT00573144 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
NCT03370835 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease
NCT00090558 ·Status: COMPLETED ·Phase: PHASE2
-
A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants
NCT01902550 ·Status: WITHDRAWN ·Phase: PHASE1